Electrophysiological evidence for an antinociceptive effect of ketamine in the rat spinal cord

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 4, 1998, Pages 435-441

  Hao, J X ^a   Sjolund B H ^b   Wiesenfeld Hallin, Z ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

C fibers; Dorsal horn neurons; Flexon reflex; NMDA receptors; Pain; Spinal cord

Indexed keywords

KETAMINE; NALOXONE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; FEMALE; FLEXOR REFLEX; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROTRANSMISSION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SPINAL ANIMAL; SPINAL CORD;

EID: 0031885773     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05138.x     Document Type: Article

References (43)

1. Maurset A, Skoglund LS, Hustveit O, Oye L. Comparison of ketamine and pethidine in experimental and post-operative pain. Pain 1989: 36: 37-41.
2. Stannard CF, Porter GE. Ketamine hydrochloride in the treatment of phantom limb pain. Pain 1993: 54: 227-230.
3. Hoffmann V, Coppejans H, Vercauteren M, Adriaensen H. Successful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain 1994: 10: 240-242.
4. Arendt-Nielsen L, Petersen-Felix S, Fischer M, Bak P, Bjerring P, Zbinden AM. The effect of N-methyl-D-aspartate antagonist (ketamine) on single and repeated nociceptive stimuli: a placebo-controlled experimental human study. Anesth Analg 1995: 31: 63-68.
5. Cherry DA, Plummer JL, Gourlay GK, Coates KR, Odgers CL. Ketamine as an adjunct to morphine in the treatment of pain. Pain 1995: 62: 119-121.
6. Mathisen LC, Skjelbred P, Skoglund LA, Oye L. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 1995: 61: 215-220.
7. Park KM, Max MB, Robinovitz E, Gracely RH, Bennett GJ. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. Pain 1995: 63: 163-172.
8. Persson J, Axelsson G, Hallin RG, Gustafsson LL. Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization. Pain 1995: 60: 217-222.
9. Tung AS, Yaksh TL. Analgesic effect of intrathecal ketamine in the rat. Reg Anesth 1981: 6: 91-94.
10. Collins JG. Effects of ketamine on low intensity tactile sensory input are not dependent upon a spinal site of action. Anesth Analg 1986: 65: 1123-1129.
11. Crisp T, Perrotti JM, Smith DL, Stafinsky JL, Smith DJ. The local monoaminergic dependency of spinal ketamine. Eur J Pharmacol 1991: 194: 167-172.
12. Qian J, Brown SD, Carlton SM. Systemic ketamine attenuates nociceptive bahaviors in a rat model of peripheral neuropathy. Brain Res 1996: 715: 51-62.
13. Meller ST. Ketamine: relief from chronic pain through actions at the NMDA receptor? Pain 1996: 68: 435-436.
14. Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammlian neurones by N-methyl-D-aspartate. Br J Pharmacol 1983: 79: 565-575.
15. Lehmann J, Loo P, McPherson S, French-Mullen IMH, Steel D, Braunwalder A et al. NMDA- and PCP-type receptor interactions in excitatory amino acid transmission. In: T.P. Hicks, D. Lodge and H. Mclennan (eds.). Excitatory Amino Acid Transmission. New York: Liss, 1987: 91-98.
16. Maurset A, Skoglund LA, Oye I. The analgesic action of ketamine is nonopoiod and mediated by PCP receptors. In: E.F. Domino and J.M. Kamenka (eds.). Sigma Opioid Phencyclidine-like compounds as molecular probes in biology. Ann Arbor, Ml: NPP Books, 1988: 541-544.
17. Kress HG. Actions of ketamine not related to NMDA and opiate receptors. Anaesthesist 1994: 43 (Suppl. 2): S15-S24.
18. Pekoe GM, Smith DJ. The involvement of opiate and monoaminergic neuronal systems in the analgesic effects of ketamine. Pain 1982: 12: 57-73.
19. Finck AD, Ngai SH. Opiate receptor mediation of ketamine analgesia. Anesthesiology 1982: 56: 291-297.
20. Fratta W, Casu M, Balestrieri A, Loviselli A, Biggio G, Gessa GL. Failure of ketamine to interact with opiate receptors. Eur J Pharmacol 1980: 61: 389-391.
21. Takahashi RN, Morato GS, Rae GA. Effects of ketamine on nociception and gastrointestinal motility in mice are unaffected by naloxone. Gen Pharmacol 1987: 18: 201-203.
22. Dubner R, Ruda MA. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci 1992: 15: 96-103.
23. Coderre TJ, Katz J, Vaccarino AL, Melzack, R. Contribution of central neuroplasticity to pathological pain: review of clinical and experiment evidence. Pain 1993: 52: 259-280.
24. Meller ST. Thermal and mechanical hyperalgesia. A distinct role for different excitatory aminoacid receptors and signal transduction pathways? Am Pain Soc J 1994: 3: 215-231.
25. Conseiller C, Benoist JM, Hamann KF, Maillard MC, Besson JM. Effects of ketamine (CI581) on cell responses to cutaneous stimulation in laminae IV and V in the cat's dorsal horn. Eur J Pharmacol 1972: 18: 346-352.
26. Kitahata LM, Taub A, Kosaka Y. Lamina-specific suppression of dorsal horn unit activity by ketamine hydrochloride. Anesthesiology 1973: 38: 4-11.
27. Auja BR. Analgesic effect of intrathecal ketamine in rats. Br J Anaesth 1983: 55: 991-995.
28. Ohtani M, Kikuchi H, Kitahata LM, Taub A, Toyooka H, Hanaoka K et al. Effects of ketamine on nociceptive cells in the medial medullary reticular formation of the cat. Anesthesiohgy 1979: 51: 414-417.
29. Okuda T. Comparison of direct and indirect depressant actions of ketamine on dorsal horn cells in rabbits. Neuropharmacology 1986: 25: 433-440.
30. Schouenborg J, Sjölund BH. Activity evoked by A- and C-afferent fibers in rat dorsal horn neurons and its relation to a flexion reflex. J Neurophysiol 1983: 50: 1108-1121.
31. Nagasaka H, Nagasaka I, Sato I, Matsumoto N, Matsumoto I, Hori T. The effects of ketamine on the excitation and inhibition of dorsal horn WDR neuronal activity induced by bradykinin injection into the femoral artery in cats after spinal cord transection. Anesthesiology 1993: 78: 722-732.
32. Isles JF, Astorga J, Laredo M. Epidural ketamine for control of postoperative pain. Anesth Analg 1993: 64: 1161-1162.
33. Headley PM, Parsons CG, West DC. The role of N-methylaspartate receptors in mediating responses of rat and cat spinal neurones to defined sensory stimuli. J Physiol 1987: 385: 169-188.
34. Davies SN, Lodge D. Evidence for involvement of N-methylaspartate receptors in "wind-up" of class 2 neurones in the dorsal horn of the rat. Brain Res 1987: 424: 402-406.
35. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency-dependent potentiation of deep rat dorsal horn nociceptive neurones following C-fiber stimulation. Neuropharmacology 1987: 26: 1235-1238.
36. Dickenson AH, Sullivan AF. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat. Brain Res 1990: 506: 31-39.
37. Raigorodsky G, Urea G. Involvement of N-methyl-D-aspartate receptors in nociception and motor control in the spinal cord of the mouse: behavioral, pharmacological and electrophysiological evidence. Neuroscience 1990: 36: 601-608.
38. Dougherty PM, Palecek J, Paleckova V, Sorkin LS, Willis WD. The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. J Neurosci 1992: 12: 3025-3041.
39. Raigorodsky G, Urea G. Intrathecal N-methyl-D-aspartate (NMDA) activates both nociceptive and antinociceptive systems. Brain Res 1987: 422: 158-163.
40. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ. Differential roles of NMDA and non-NMDA receptor activation in induction and maintainance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res 1991: 598: 271-278.
41. Näsström J, Karlsson U, Post C. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice. Enr J Pharmacol 1992: 212: 21-27.
42. Smith DJ, Bouchal RL, DeSanctis CA, Monroe PJ, Amedro JB, Perrotti JM et al. Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro. Neuropharmacology 1987: 26: 1253-1260.
43. Seth S, Mukherjee D, Choudhary AK, Sinha JN, Gurtu S. Opioid and non-opioid central cardiovascular effects of ketamine. Naunyn-Schmiedeberg's Arch Pharmacol 1990: 342: 535-538.